首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-gamma induced PD-L1 expression (vol 185, 111725, 2020)
【24h】

N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-gamma induced PD-L1 expression (vol 185, 111725, 2020)

机译:N-烷基 - 羟基苯甲酰苯胺羟肟酸盐作为HDAC和HSP90的双重抑制剂,下调IFN-Gamma诱导PD-L1表达(Vol 185,111725,2020)

获取原文
获取原文并翻译 | 示例
           

著录项

  • 来源
  • 作者单位

    Taipei Med Univ Sch Pharm Coll Pharm Taipei Taiwan;

    Taipei Med Univ Sch Pharm Coll Pharm Taipei Taiwan;

    Taipei Med Univ Coll Med Sci &

    Technol PhD Program Canc Biol &

    Drug Discovery Taipei Taiwan;

    Taipei Med Univ Sch Med Dept Pharmacol Coll Med Taipei Taiwan;

    Univ Coll Pharm PhD Program Clin Drug Discovery Bot Herbs Taipei Taiwan;

    Taipei Med Univ Grad Inst Pharmacognosy Coll Pharm Taipei Taiwan;

    Taipei Med Univ Grad Inst Canc Mol Biol &

    Drug Discovery Coll Med Sci &

    Technol Taipei Taiwan;

    Taipei Med Univ Grad Inst Canc Mol Biol &

    Drug Discovery Coll Med Sci &

    Technol Taipei Taiwan;

    Taipei Med Univ Grad Inst Canc Mol Biol &

    Drug Discovery Coll Med Sci &

    Technol Taipei Taiwan;

    Univ Coll Pharm PhD Program Clin Drug Discovery Bot Herbs Taipei Taiwan;

    Taipei Med Univ Sch Pharm Coll Pharm Taipei Taiwan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号